Format

Send to

Choose Destination
Head Neck. 2019 Feb;41(2):536-541. doi: 10.1002/hed.25479. Epub 2018 Dec 7.

Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.

Author information

1
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida.
2
University of Florida Health Proton Therapy Institute, University of Florida College of Medicine, Jacksonville, Florida.

Abstract

BACKGROUND:

Skull base chordomas and chondrosarcomas are rare tumors traditionally treated by surgical resection and adjuvant radiation therapy (RT). We will discuss data evaluating clinical outcomes of proton therapy in the treatment of skull base chordomas and chondrosarcomas.

METHODS:

A literature review was performed using a MEDLINE search from January 1990 to January 2017.

RESULTS:

The published data suggest that the dose intensification allowed by proton therapy has resulted in good clinical outcomes and a tolerable toxicity profile.

CONCLUSION:

Proton therapy is a modern RT technique that has demonstrated improved preliminary clinical outcomes in the treatment of skull base chordomas and chondrosarcomas compared to conventional radiotherapy, and comparable to other advanced photon-based RT techniques.

KEYWORDS:

chondrosarcomas; chordomas; proton therapy; radiation oncology; skull-based tumors

PMID:
30537295
DOI:
10.1002/hed.25479

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center